rs144968714
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BA1
This summary comes from the ClinGen Evidence Repository: NM_000215.4(JAK3):c.3268G>A is a missense variant predicted to cause substitution of Alanine by Threonine at amino acid 1090 (p.Ala1090Thr). The filtering allele frequency (the lower threshold of the 95% CI of 373/75020) of the c.3268G>A variant in JAK3 is 0.004556 for African/African American chromosomes by gnomAD v4, which is higher than the ClinGen SCID VCEP threshold (>0.00447) for BA1, and therefore meets this criterion (BA1).In summary, this variant meets the criteria to be classified as Benign for autosomal recessive severe combined immunodeficiency due to JAK3 deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen SCID VCEP: BA1 (VCEP specifications version 1). LINK:https://erepo.genome.network/evrepo/ui/classification/CA160243/MONDO:0010938/121
Frequency
Consequence
NM_000215.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
JAK3 | NM_000215.4 | c.3268G>A | p.Ala1090Thr | missense_variant | 24/24 | ENST00000458235.7 | NP_000206.2 | |
JAK3 | XM_047438786.1 | c.3268G>A | p.Ala1090Thr | missense_variant | 24/24 | XP_047294742.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
JAK3 | ENST00000458235.7 | c.3268G>A | p.Ala1090Thr | missense_variant | 24/24 | 5 | NM_000215.4 | ENSP00000391676 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00141 AC: 215AN: 152154Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000346 AC: 86AN: 248674Hom.: 0 AF XY: 0.000253 AC XY: 34AN XY: 134644
GnomAD4 exome AF: 0.000262 AC: 383AN: 1461634Hom.: 3 Cov.: 32 AF XY: 0.000230 AC XY: 167AN XY: 727102
GnomAD4 genome AF: 0.00141 AC: 214AN: 152272Hom.: 0 Cov.: 32 AF XY: 0.00137 AC XY: 102AN XY: 74452
ClinVar
Submissions by phenotype
T-B+ severe combined immunodeficiency due to JAK3 deficiency Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
Benign, reviewed by expert panel | curation | ClinGen Severe Combined Immunodeficiency Variant Curation Expert Panel, ClinGen | Apr 03, 2024 | NM_000215.4(JAK3):c.3268G>A is a missense variant predicted to cause substitution of Alanine by Threonine at amino acid 1090 (p.Ala1090Thr). The filtering allele frequency (the lower threshold of the 95% CI of 373/75020) of the c.3268G>A variant in JAK3 is 0.004556 for African/African American chromosomes by gnomAD v4, which is higher than the ClinGen SCID VCEP threshold (>0.00447) for BA1, and therefore meets this criterion (BA1). In summary, this variant meets the criteria to be classified as Benign for autosomal recessive severe combined immunodeficiency due to JAK3 deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen SCID VCEP: BA1 (VCEP specifications version 1). - |
not provided Benign:1
Likely benign, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The JAK3 p.Ala1090Thr variant was not identified in the literature but was identified in dbSNP (ID: rs144968714), ClinVar (classified as likely benign by Invitae) and LOVD 3.0 (variant effect not shared). The variant was identified in control databases in 127 of 280068 chromosomes at a frequency of 0.0004535 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: African in 105 of 24964 chromosomes (freq: 0.004206), Other in 6 of 7206 chromosomes (freq: 0.000833), Latino in 6 of 35430 chromosomes (freq: 0.000169) and East Asian in 3 of 19948 chromosomes (freq: 0.00015), European (non-Finnish) in 7 of 126746 chromosomes (freq: 0.000055), but was not observed in the Ashkenazi Jewish, European (Finnish), or South Asian populations. The p.Ala1090 residue is not conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. - |
not specified Other:1
not provided, no classification provided | reference population | ITMI | Sep 19, 2013 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at